Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | melatonin receptor 1A | Starlite/ChEMBL | References |
Homo sapiens | NAD(P)H dehydrogenase, quinone 2 | Starlite/ChEMBL | References |
Homo sapiens | melatonin receptor 1B | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | NAD(P)H dehydrogenase, quinone 2 | 231 aa | 213 aa | 26.3 % |
Brugia malayi | hypothetical protein | melatonin receptor 1B | 362 aa | 329 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 0.2998 | 1 |
Onchocerca volvulus | 0.0096 | 0.2996 | 0.5 | |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0166 | 0.6539 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0166 | 0.6539 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0166 | 0.6539 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0072 | 0.1783 | 0.5948 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0143 | 0.5369 | 1 |
Trypanosoma brucei | glucosidase, putative | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 0.2998 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0166 | 0.6539 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 0.2998 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0096 | 0.2998 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0096 | 0.2998 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0037 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0166 | 0.6539 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0096 | 0.2998 | 1 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0037 | 0 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0143 | 0.5369 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.17 | Displacement of [125I]iodomelatonin from MT3/QR2 melatonin binding site expressed in CHO cells | ChEMBL. | 18400335 |
IC50 (binding) | > 10000 nM | Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells | ChEMBL. | 18372181 |
IC50 (binding) | > 10000 nM | Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cells | ChEMBL. | 18372181 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.